Vincerx Pharma | 4:持股变动声明-高管 Seelenberger Alexander A.
Vincerx Pharma | 4:持股变动声明-高管 Izumi Raquel E.
Vincerx Pharma | 4:持股变动声明-高管 THOMAS TOM C
Vincerx Pharma | 4:持股变动声明-高管 Hamdy Ahmed MD
Vincerx Pharma | 4:持股变动声明-董事 Salva Francisco D.
Vincerx Pharma | 4:持股变动声明-董事 Stevens Ruth E.
Vincerx Pharma | 4:持股变动声明-董事 Druker Brian
Vincerx Pharma | 4:持股变动声明-董事 Bushnell Laura I.
Vincerx Pharma | 4:持股变动声明-董事 Lee John H.
Vincerx Pharma | SC 13G:超过5%持股股东披露文件-Prosight Management, LP(9.1%),Prosight Partners, LLC(9.1%)等
Vincerx Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-THE GOLDMAN SACHS GROUP, INC.(3.0 %),GOLDMAN SACHS & CO. LLC(3.0 %)
Vincerx Pharma | 4:持股变动声明-高管 Izumi Raquel E.
Vincerx Pharma | 4:持股变动声明-高管 Seelenberger Alexander A.
Vincerx Pharma | 4:持股变动声明-高管 Hamdy Ahmed MD
Vincerx Pharma | 4:持股变动声明-高管 THOMAS TOM C
Vincerx Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-LONG FOCUS CAPITAL MANAGEMENT, LLC(5.1%),JOHN B. HELMERS(5.1%)等
Vincerx Pharma | SC 13G:超过5%持股股东披露文件-BANK OF AMERICA CORPORATION(5.1%)
Vincerx Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-Affinity Healthcare Fund, LP (EIN(0%),Affinity Asset Advisors, LLC (EIN(0%)
Vincerx Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-THE GOLDMAN SACHS GROUP, INC.(8.0 %),GOLDMAN SACHS & CO. LLC(8.0 %)
Vincerx Pharma | 4:持股变动声明-高管 Seelenberger Alexander A.
暂无数据